Repligen Corporation News
10 must-know biotech stock events to close out 2016
Important clinical trial results in Alzheimer's, cancer and Crohn's disease and a big FDA decision for Sarepta are expected before the end of the year.
Trade-Ideas: Repligen (RGEN) Is Today's Weak On High Relative Volume Stock
Trade-Ideas LLC identified Repligen (RGEN) as a weak on high relative volume candidate
Today's Dead Cat Bounce Stock Is Repligen (RGEN)
Trade-Ideas LLC identified Repligen (RGEN) as a "dead cat bounce" (down big yesterday but up big today) candidate
Insider Trading Alert - RGEN, DVA And FLT Traded By Insiders
Stocks with insider trader activity include RGEN, DVA and FLT
Trade-Ideas: Repligen (RGEN) Is Today's New Lifetime High Stock
Trade-Ideas LLC identified Repligen (RGEN) as a new lifetime high candidate
Disney Mobile Game Opens Up a New Universe
Familiar Disney characters populate an alternate reality in new interactive game.
Birth Control Stocks May Benefit From the Reversal of Roe v. Wade
The historic Supreme Court decision may force women to make different choices.
Roe Decision Forces Disney, Netflix to Take a Political Stand
Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.